FI963132A0 - Diastereomeriskt rena trifluormetylketonpeptid derivat som inhibitorer av människans leukocytelastas - Google Patents

Diastereomeriskt rena trifluormetylketonpeptid derivat som inhibitorer av människans leukocytelastas

Info

Publication number
FI963132A0
FI963132A0 FI963132A FI963132A FI963132A0 FI 963132 A0 FI963132 A0 FI 963132A0 FI 963132 A FI963132 A FI 963132A FI 963132 A FI963132 A FI 963132A FI 963132 A0 FI963132 A0 FI 963132A0
Authority
FI
Finland
Prior art keywords
inhibitors
human leukocyte
peptide derivatives
diastereomerically pure
leukocyte elastase
Prior art date
Application number
FI963132A
Other languages
English (en)
Finnish (fi)
Other versions
FI963132A (sv
Inventor
Stephen John Pegg
George Joseph Sependa
Elwyn Peter Davies
Chris Allan Veale
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421550A external-priority patent/GB9421550D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of FI963132A0 publication Critical patent/FI963132A0/sv
Publication of FI963132A publication Critical patent/FI963132A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI963132A 1994-02-11 1996-08-09 Diastereomeriskt rena trifluormetylketonpeptid derivat som inhibitorer av människans leukocytelastas FI963132A (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9402680A GB9402680D0 (en) 1994-02-11 1994-02-11 Pyrrolidine derivatives
GB9421550A GB9421550D0 (en) 1994-10-26 1994-10-26 Heterocyclic derivative
PCT/GB1995/000242 WO1995021855A1 (en) 1994-02-11 1995-02-07 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase

Publications (2)

Publication Number Publication Date
FI963132A0 true FI963132A0 (sv) 1996-08-09
FI963132A FI963132A (sv) 1996-08-09

Family

ID=26304315

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963132A FI963132A (sv) 1994-02-11 1996-08-09 Diastereomeriskt rena trifluormetylketonpeptid derivat som inhibitorer av människans leukocytelastas

Country Status (20)

Country Link
US (3) US5739157A (sv)
EP (1) EP0743953B1 (sv)
JP (1) JP3416142B2 (sv)
CN (1) CN1140455A (sv)
AT (1) ATE174034T1 (sv)
AU (1) AU692515B2 (sv)
CA (1) CA2180006A1 (sv)
DE (1) DE69506380T2 (sv)
DK (1) DK0743953T3 (sv)
ES (1) ES2125004T3 (sv)
FI (1) FI963132A (sv)
GB (1) GB9402680D0 (sv)
HK (1) HK1011033A1 (sv)
IL (1) IL112613A (sv)
MX (1) MX9603291A (sv)
NO (1) NO313882B1 (sv)
NZ (1) NZ279265A (sv)
TW (1) TW414801B (sv)
WO (1) WO1995021855A1 (sv)
YU (1) YU7195A (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
GB9502152D0 (en) * 1995-02-03 1995-03-29 Zeneca Ltd Proline derivatives
AU7261196A (en) * 1995-10-10 1997-04-30 Eli Lilly And Company N-{2-substituted-3-(2-aminoethyl)-1h-indol-5-yl}-amides: new 5-ht1f agonists
ATE261969T1 (de) * 1996-03-28 2004-04-15 Glaxo Group Ltd Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9719172D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9719187D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
CA2498052C (en) 2002-09-10 2011-05-17 Bayer Healthcare Ag Heterocyclic derivatives
WO2005080372A1 (en) 2004-02-19 2005-09-01 Bayer Healthcare Ag Dihydropyridinone derivatives
DE102005037791A1 (de) * 2005-08-10 2007-02-15 Ernst-Moritz-Arndt Universität Greifswald Verwendung von spezifischen Trifluormethylketonen zur Vorbeugung und Behandlung einer Pankreatitis
MX2009005252A (es) * 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
CN103226756A (zh) * 2013-04-28 2013-07-31 文俊 工艺品生产过程的工艺制作及生产过程的记录方法和系统
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
EP4252850A3 (en) 2020-04-16 2023-11-15 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
WO2023067103A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5194588A (en) * 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives

Also Published As

Publication number Publication date
GB9402680D0 (en) 1994-04-06
DE69506380D1 (de) 1999-01-14
JP3416142B2 (ja) 2003-06-16
NZ279265A (en) 1998-01-26
WO1995021855A1 (en) 1995-08-17
CN1140455A (zh) 1997-01-15
ATE174034T1 (de) 1998-12-15
CA2180006A1 (en) 1995-08-17
EP0743953A1 (en) 1996-11-27
EP0743953B1 (en) 1998-12-02
ES2125004T3 (es) 1999-02-16
AU1583995A (en) 1995-08-29
FI963132A (sv) 1996-08-09
NO963329D0 (no) 1996-08-09
IL112613A0 (en) 1995-05-26
DK0743953T3 (da) 1999-08-16
AU692515B2 (en) 1998-06-11
NO313882B1 (no) 2002-12-16
US6037363A (en) 2000-03-14
US5739157A (en) 1998-04-14
JPH09508902A (ja) 1997-09-09
IL112613A (en) 2000-02-29
TW414801B (en) 2000-12-11
NO963329L (no) 1996-10-09
HK1011033A1 (en) 1999-07-02
YU7195A (sh) 1998-09-18
MX9603291A (es) 1997-02-28
US5907043A (en) 1999-05-25
DE69506380T2 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
FI963132A0 (sv) Diastereomeriskt rena trifluormetylketonpeptid derivat som inhibitorer av människans leukocytelastas
DE69314169T2 (de) Peptide mit eine alphaaminoboronaire gruppe and ihre verwendung als elastasehemmer
NO943910D0 (no) Laktam-peptider med HLE-hemmende virkning
DE69931393D1 (de) Antithrombotische amide
ES2099186T3 (es) Nuevos inhibidores de elastasa activos por via oral.
NO943909L (no) Laktam-dipeptider som har HLE-inhiberende aktivitet
NO973539D0 (no) Prolinderivater anvendelige som inhibitorer for human leukocyttelastase
MY136859A (en) Pyrrolidine derivatives as factor xa inhibitors
ATE171191T1 (de) Fluorenthaltende dipeptide als inhibitoren gegen elastase menschliches leukocyten
AU622316B2 (en) Fluoro-amide derivatives
DK0399688T3 (da) Trifluorketopeptidderivater, som er nyttige som human leukocyt-elastaseinhibitorer
WO2003104189A3 (en) COMPOUNDS